Uncategorized

1902-31802

Improving Access to Abortion in Georgia

  Center for Information and Counseling on Reproductive Health – Tanadgoma
   Georgia

Tanadgoma improves access to abortion for women in Georgia by implementing and testing a simplified one-visit service delivery model, as opposed to three visits typically required to have an abortion. The only visit to a health facility will be for pregnancy diagnosis and counselling. Meeting local legal requirements, five days later, the health provider will receive remote confirmation from the patient about whether they are still seeking an abortion. The provider will then mail medical abortion pills and two urine pregnancy tests to the patient. As such, the medical abortion can be self-administered, and the success can be confirmed without an in-person assessment.

Uncategorized

1902-31796

Mifepristone 50 mg as a Contraceptive

  Women on Web                 Georgia

Women on Web International Foundation’s innovation is a non-inferiority clinical trial in Georgia, comparing the contraceptive use of weekly mifepristone with the daily use of desogestrel, an alternative non-estrogen contraceptive. The trial aims to establish the efficacy, safety and side-effects of mifepristone as a weekly contraceptive. The long-term goal of the innovation is to register and market mifepristone as a contraceptive and to have this indication included on the World Health Organization Essential Medicines List.